Metformin targets Mitochondrial Glycerophosphate Dehydrogenase (mGPDH) to control Rate of Oxidative Phosphorylation and growth of thyroid cancer in vitro and in vivo by Thakur, Shilpa, Daley, Brianna, Gaskins, Kelli, Vasko, Vasyl V, Boufraqech, Myriem, Patel, Dhaval, Sourbier, Carole, Reece, Jeff M, Cheng, Sheue-Yann, Kebebew, Electron, Agarwal, Sunita K, Klubo-Gwiezdzinska, Joanna

Get full text

Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases by Kotian, Shweta, Zhang, Lisa, Boufraqech, Myriem, Gaskins, Kelli, Gara, Sudheer Kumar, Quezado, Martha, Nilubol, Naris, Kebebew, Electron

Get full text

RARRES2 functions as a tumor suppressor by promoting β-catenin phosphorylation/degradation and inhibiting p38 phosphorylation in adrenocortical carcinoma by Liu-Chittenden, Y, Jain, M, Gaskins, K, Wang, S, Merino, M J, Kotian, S, Kumar Gara, S, Davis, S, Zhang, L, Kebebew, E

Get full text

Serum RARRES2 Is a Prognostic Marker in Patients With Adrenocortical Carcinoma by Liu-Chittenden, Yi, Patel, Dhaval, Gaskins, Kelli, Giordano, Thomas J, Assie, Guillaume, Bertherat, Jerome, Kebebew, Electron

Get full text

Abstract 3664: RARRES2 functions as a direct tumor suppressor by promoting beta-catenin phosphorylation and degradation independent of CMKLR1 and CMKLR1-mediated antitumor immune r... by Liu-Chittenden, Yi, Gaskins, Kelli, Wang, Sophie, Kebebew, Electron

Get full text

A combinatorial strategy for targeting BRAFV600E mutant cancers with BRAFV600E inhibitor (PLX4720) and tyrosine kinase inhibitor (ponatinib) by Ghosh, Chandrayee, Kumar, Suresh, Kushchayeva, Yevgeniya, Gaskins, Kelli, Boufraqech, Myriem, Wei, Darmood, Gara, Sudheer Kumar, Zhang, Lisa, Zhang, Ya-Quin, Shen, Min, Mukherjee, Sanjit, Kebebew, Electron

Get full text

GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3 by Gara, Sudheer Kumar, Tyagi, Monica Varun, Patel, Dhaval Thakkur, Gaskins, Kelli, Lack, Justin, Liu, Yi, Kebebew, Electron

Get full text

A Combinatorial Strategy for Targeting BRAF V600E-Mutant Cancers with BRAFV600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib) by Ghosh, Chandrayee, Kumar, Suresh, Kushchayeva, Yevgeniya, Gaskins, Kelli, Boufraqech, Myriem, Wei, Darmood, Gara, Sudheer Kumar, Zhang, Lisa, Zhang, Ya-qin, Shen, Min, Mukherjee, Sanjit, Kebebew, Electron

Get full text

Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors by Nilubol, Naris, Yuan, ZiQiang, Paciotti, Giulio F, Tamarkin, Lawrence, Sanchez, Carmen, Gaskins, Kelli, Freedman, Esther M, Cao, Shugeng, Zhao, Jielu, Kingston, David G I, Libutti, Steven K, Kebebew, Electron

Get full text

Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response by Nilubol, Naris, Boufraqech, Myriem, Zhang, Lisa, Gaskins, Kelli, Shen, Min, Zhang, Ya-Qin, Gara, Sudheer K, Austin, Christopher P, Kebebew, Electron

Get full text

A Combinatorial Strategy for Targeting BRAF V600E -Mutant Cancers with BRAF V600E Inhibitor (PLX4720) and Tyrosine Kinase Inhibitor (Ponatinib) by Ghosh, Chandrayee, Kumar, Suresh, Kushchayeva, Yevgeniya, Gaskins, Kelli, Boufraqech, Myriem, Wei, Darmood, Gara, Sudheer Kumar, Zhang, Lisa, Zhang, Ya-Qin, Shen, Min, Mukherjee, Sanjit, Kebebew, Electron

Get full text